If you started a new medication for a service-connected condition and noticed your tinnitus getting worse within weeks or months, the medication may be the cause, and that's a separate secondary VA claim worth pursuing. Not all tinnitus originates from noise exposure. A significant subset of veterans develops tinnitus, or experiences worsening of existing tinnitus, as a side effect of medications prescribed to treat other service-connected conditions. When that happens, the tinnitus may be service-connected on a secondary basis, even if military noise never played a role.
Secondary service connection is established under 38 CFR 3.310. It requires showing that a current disability was caused or aggravated by an already service-connected condition. Tinnitus caused by medications taken for a service-connected condition fits this framework precisely, because the service-connected condition is what necessitated the medication.
The chain of causation runs like this: service-connected condition requires medication, medication causes tinnitus, therefore tinnitus is secondary to the service-connected condition.
VA courts have consistently upheld secondary service connection claims that follow this logic, including Allen v. Principi (237 F.3d 1368, Fed Cir 2001), which broadly supported secondary connection for conditions proximately caused by service-connected disabilities.
The medical literature identifies several drug classes and specific agents as ototoxic, meaning capable of damaging the inner ear or auditory nerve in ways that produce or worsen tinnitus. These include:
Analgesics and anti-inflammatory agents:
Antibiotics:
Antimalarial medications:
Loop diuretics:
Chemotherapy agents:
Other agents:
The risk of ototoxicity varies by dose, duration, route of administration, and individual susceptibility. Veterans with pre-existing noise-induced cochlear damage may be more vulnerable to medication-induced tinnitus because the hair cells are already compromised.
Building a secondary tinnitus claim on a medication basis requires establishing:
Start with a simple self-assessment: look at your prescription history for the drug classes listed below, and match any start dates against changes in your tinnitus. If you notice that tinnitus began or worsened within weeks of starting a new medication for a service-connected condition, document that correlation. That timeline is the foundation of your secondary claim. Pull your pharmacy history from the VA or your private provider and identify which medications you've taken for service-connected conditions, how long you took them, and at what doses.
Secondary service connection applies in two scenarios: causation (the medication caused tinnitus that didn't previously exist) and aggravation (the medication worsened tinnitus that was already present).
If you already have a service-connected tinnitus rating from noise exposure, and a subsequent medication worsened that tinnitus, you may have an aggravation claim under 38 CFR 3.310(b). Aggravation must be beyond the natural progression of the condition, and the increase in severity must be documented.
Veterans in this situation should document any change in tinnitus severity that coincided with starting a new medication, ideally with audiometric evidence or consistent treatment records noting worsening symptoms.
A secondary medication-based tinnitus claim should include:
See also: Anatomy of a strong tinnitus nexus letter for the specific elements a secondary nexus opinion should address.
The medication-based pathway is underused. Many veterans, and even some VSOs, aren't aware that tinnitus can be secondary to pharmacological ototoxicity. If you've been treated with any of the drug classes listed above for a service-connected condition and have subsequently developed or noticed worsening of tinnitus, this avenue is worth evaluating with a knowledgeable physician.
It's also worth noting that medication-induced tinnitus is sometimes reversible after the drug is discontinued. If your tinnitus resolved when a medication was stopped, the claim may be harder to sustain. If it persisted, that persistence itself is evidence of a lasting ototoxic effect.
See also: Tinnitus and hearing loss: how they relate for context on cochlear damage mechanisms.
If you're exploring a secondary tinnitus claim based on medication ototoxicity, Flat Rate Nexus offers physician-signed nexus opinions that specifically address the pharmacological causation pathway. Visit flatratenexus.com/tinnitus.html for more information.
Thinking about your own claim? Every nexus letter we write goes through a full physician record review, cites peer-reviewed research, and is built around the actual evidence in your case.
Start My Nexus Letter